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Abstract
Sophorolipids (SL) are amphiphilic biosurfactant molecules consisting of a disaccharide
sophorose with one fatty acid at the C1 position and optional acetylation at the C6’and C6”
positions. They exist in a closed ring lactonic (LSL) or open acidic (ASL) structure Sophor-
olipids are produced in crude mixtures in economically viable amounts by the yeast Star-
merella bombicola and used in a variety of consumer products. Varying levels of anti-
proliferative and anti-cancer activity of crude sophorolipid mixtures are described in a
number of tumor cell lines in vitro. However, significant inter-study variation exists in the
composition of sophorolipid species as well as other biologically active compounds in
these mixtures, which makes interpretation of in vitro and in vivo studies difficult. We pro-
duced a 96% pure C18:1 lactonic sophorolipid that dose-dependently reduces the viability
of colorectal cancer, as well as normal human colonic and lung cell lines in vitro. Oral
administration of vehicle-only; or lactonic sophorolipids (50 mg/kg for 70 days), to
Apcmin+/- mice resulted in an increase in the number (55.5 ± 3.3 vs 70.50 ± 7.8: p < 0.05)
and size (modal size 2mm vs 4mm) of intestinal polyps. Lactonic administration resulted
in a systematic effect via reduced hematocrit (49.5 ± 1.0 vs 28.2 ± 2.0 vs: p<0.03) and
splenomegaly (0.56 ± 0.03g vs 0.71 ± 0.04g; p<0.01) confirming exacerbation of disease
progression in this model.
Introduction
Biosurfactants are produced by a variety of microorganisms as secondary metabolites, forming
emulsions that reduce both interfacial and surface tension [1]. Due to their increased biode-
gradability, low toxicity and ability to exert an effect at extreme temperatures and pH levels [2],
they prove versatile for a wide range of biomedical and industrial applications [3]. Currently, a
range of microbial biosurfactants are used in cleaning supplies [4], pesticides [5], textiles [6]
and cosmetics [7] while petroleum derived surfactants are still used in food products [8] and
over the counter creams [9]. Microbial biosurfactants are a diverse group of surface- active
compounds classified by their chemical structure, weight and microbial origin [10]. Some well-
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known glycolipid biosurfactants include sophorolipids (SL), mannosylerythritols, trehalolipids
and rhamnolipids [11].
The SL species we describe in this study are produced by different types of yeast such as
Starmerella bombicola, Candida bastistaeic, C. floricola and C. apicola [12]. In these organisms
the SL species are composed of a hydrophobic fatty acid tail and a hydrophilic carbohydrate
head composed of a disaccharide sophorose linked by a β-1, 2 bond which is optionally acety-
lated on the 6’ and/or 6” position. The structure of SLs is dependent on a terminal or sub-ter-
minal hydroxylated fatty acid, which is linked β-glycosidically to the sophorose. The fatty
acids’ carboxylic end can be free, forming the acidic structure [13] or can be esterified at the 4”
position giving rise to the lactonic ring structure (Fig 1).
A wide range of bioactivities for SL have been documented; including antimicrobial activity
viamembrane destabilization and increased permeabilization [14] and anti-inflammatory
effects through the reduction of cytokine release and initiation of a macrophage response [15].
Several studies indicate that LSL [16–18] show greater potentials as anti-tumor, anti-microbial,
anti- fungal and spermicide agents, while ASL are more suited as moisturizing, solubilizing,
cleaning and emulsifying agents. The purity and composition of SL used in bioassays is highly
variable, with most studies not disclosing the molecular species or their relative abundances
within the mixtures [19–21]. Additionally, SL analogs and their derivatives can reduce the effi-
cacy of crude preparations [16, 19] and they are known to exhibit varying potencies and toxici-
ties depending on their manufacturing methods [22]. LSL normally make up the highest
proportion of crude preparations of SL (characteristically 70–85% [23]), with the remainder
comprised of varying amounts of ASL and other derivatives; the aforementioned consider-
ations underline the need to use purified and characterized (ASL or LSL) forms when assessing
or comparing bioactivities. In order to minimize batch to batch variation and reduce specific
congeners (2.5% ASL and<1% free fatty acids as a proportion of dry weight) we used a tightly-
controlled batch fermentation method in order to produce a stock of highly pure and well char-
acterized LSL that was used in all our in vitro and in vivo studies.
Fig 1. Lactonic Sophorolipid. The structure of C18:1 diacetylated LSL.
doi:10.1371/journal.pone.0156845.g001
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The in vitro activities of SL has been reviewed [12], with enriched preparations showing
potent cytotoxicity against human liver (HT402), lung (A549) and leukemic (HL60 & K562)
cells [24]. Cruder preparations of SL are reported to show dose-dependent, anti-proliferative
and pro- apoptotic activity against pancreatic cancer (H7402, HPAC) [19] and esophageal can-
cer (KYSE450, KYSE109) cell lines [17]. Conclusions on the specificity of such diverse prepara-
tions of SL to transformed cells is complicated by the inappropriate use of controls—many
studies lack the use of appropriate primary or non-transformed cells such as non-adherent
peripheral blood mononuclear cells (PBMCs) [25].
Despite a number of studies showing that SL preparations have anti-proliferative effects on
tumor cell lines, to our knowledge the anti-tumor effects of these compounds in vivo has not
been reported. However, SL mixtures have been shown to reduce mortality and regulate nitric
oxide production in a rat model of peritoneal sepsis [14], as well as reducing IgE production
[26] following nebulizer administration in a mouse model of asthma [27]. These pre-clinical
studies are consistent with the proposal that parenteral administration of relatively low doses
of SL is safe and non-toxic in-vivo.
We hypothesized that purified forms of LSL would specifically inhibit colorectal tumor cell
growth both in vitro and in vivo. Therefore, we purified and characterized a LSL preparation
produced by Starmerella bombicola and assessed its’ effects on five unrelated colorectal cancer
cell lines: HT29, HT115, HCT116, Caco-2 and LS180, in addition to two non-transformed
lines: normal human colonic epithelium CCD-841 CoN and lung fibroblast MRC5. In addition,
we administered 50mg/kg of LSL orally for 70 days to Apcmin+/- mice (a well-established model
of colorectal neoplasia) [28, 29], to determine its’ ability to inhibit tumor growth in vivo.
Materials and Methods
Sophorolipid production and purification
A lactonesterase overexpressing strain of Starmerella bombicola (oe sble) as described by Roe-
lants et al. [30] was used for the production of 96% pure lactonic diacetylated SL. HPLC- ELSD
and LC-MS analysis was performed as described by Roelants et al. [30].
Cell culture
The colorectal cancer cell lines HT29 (ATCC1HTB-38), HT115 (ECACC-cultures 85061104)
HCT116 (ATCC1 CCL-247), LS180 (ATCC1 CL-187), Caco-2 (ATCC1HTB-37), normal
colonic epithelium CCD-841-CoN (ATCC1 CRL-1790) and lung fibroblasts MRC5 (ATCC1
CCL-171) were maintained in DMEMmedia supplemented with 10% fetal bovine serum
(Gibco Invitrogen; Paisley, UK). All cultures were maintained at 37°C and at 5% CO2.
MTT assay
A total of 5x104 cells per well were seeded (96 well plate: Nunc Thermos scientific, UK) and
allowed to attach overnight before being serum starved for 24h. Various concentrations of LSL
(0.001 μg/ml– 100 μg/ml) were added to the cultures and incubated for another 24h. Subse-
quently, 10μl of a 25mg/ml solution of MTT (3-(4, 5-dimethylthiazol-2-yl) -2, 5- diphenyltetra-
zolium bromide; (Sigma-Aldrich Company Ltd, Dorset, UK) was added to each well and the
plate was further incubated for 1h at 37°C. The formazan crystals were solubilized with 100μl
of DMSO (Sigma-Aldrich Company Ltd, Dorset, UK) and the absorbance at 570nm was read
on a spectrophotometer plate-reader (BMG-LABTECH, Omega, Aylesbury, Bucks UK). Each
experiment was repeated 3 times with 6 internal repeats per group.
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Acridine orange/ethidium bromide staining and quantitation
To determine the number of necrotic or apoptotic cells induced by addition of LSL, cells were
stained in situ with 10mg/ml acridine orange (Sigma-Aldrich Company Ltd, Dorset, UK) and
1mg/ml ethidium bromide (Sigma-Aldrich Company Ltd, Dorset, UK) and morphological
changes were assessed by fluorescence microscopy [31]. For assessment of apoptosis, a total of
3x104 cells were seeded onto a 10mm coverslip (Agar Scientific; Stansted, Essex, UK) and incu-
bated overnight to form a confluent monolayer. Following serum starvation for 24h, LSL
(20μg/ml or 70μg/ml) or 5μM of etoposide (control) (Sigma-Aldrich Company Ltd, Dorset,
UK) was added and the cells incubated for a further 24h. To determine the number of live cells
remaining on the coverslip the samples were washed three times with ice-cold phosphate buff-
ered saline (PBS; pH7.4, Oxoid: UK) 3 times, followed by incubation with a solution of 10μl of
1:1 acridine orange/ethidium bromide for 5 minutes and then the cells were washed 3x with
ice-cold PBS and subsequent imaging with a Zeiss florescence microscope (Axio Scope 1, Zeiss,
Germany) at a range of objective magnifications. The operator was blinded to the experimental
groups and random fields were selected (40X objective). A total of 300 attached cells per cover-
slip were morphologically identified and counted as being either necrotic (red/orange nuclei),
apoptotic (green condensed or fragmented nuclei) green or live (green non-condensed ovoid
or rounded nuclei).
Animal model
All animal procedures were approved by the animal care and ethics committee (Ulster Univer-
sity) and national (UK Home Office) ethical guidelines, and also carried out in accordance
with both local animal care committee (Ulster University) and national (UK Home Office)
guidelines by licensed personnel [32]. Apcmin+/- male and wild type (wt) female mice were
housed together for breeding purposes and subjected to a 12/12 light cycle. Food and water
were available ad libitum and weighed on a weekly basis to evaluate consumption. Animal hus-
bandry was carried out bi-weekly. Mice were monitored on a daily basis looking at grooming,
behavior, activity levels, food and water in-take and general well-being. Mice deemed un-well
were immediately removed from the study and euthanized. Body weights were monitored bi-
weekly. A cut-off point of 10% loss of body weight was applied and mice reaching this thresh-
old were euthanized immediately by CO2.
Genotyping
Ear punch samples were obtained from the 21 day old progeny of Apcmin+/-/wt crosses for the
purpose of genotyping, using primers specific for the APC mutation. DNA was isolated from
ear samples by first solubilizing them in an alkaline lysis reagent (25mMNaOH, 0.2MmM
disodium EDTA; (Sigma-Aldrich Company Ltd, Dorset, UK) at 95°C for 40 minutes, allowing
them to cool and neutralizing in Tris-HCl (40mM; (Sigma-Aldrich Company Ltd, Dorset,
UK).
Digested samples were mixed with PCR master mix (Qiagen Company Ltd, Manchester,
UK), taq (Qiagen Company Ltd, Manchester UK), nuclease free water and Apcmin+ specific
primers (100μm each) (Forward: TCT CGT TCT GAG AAA GAC AGA AGC T, Reverse: TGA TAC
TTC TTC CAA AGC TTT GGC TAT; Invitrogen Company Ltd, Paisley, UK). Samples were
placed in a thermocycler (Techne TC-5000 Gradient Thermocycler, Hanwell, London UK) and
a PCR reaction performed under the following conditions: 94°C, 2min; (94°C, 1min; 60°C,
1min; 72°C, 1min) for 30 cycles followed by 72°C for 2 minutes. PCR products were subjected
toHindIII digestion (Invitrogen, Paisley, UK) for 1h at 37°C followed by a 20 minute denatur-
ing step at 65°C. Digests were run on a 4% agarose/TBE-buffered gel (Sigma-Aldrich, Dorset,
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UK) for 40 minutes. The presence of a single band at 111bp indicated a wtmouse, while an
additional band at 123bp indicated a heterozygous Apcmin+/- mouse.
Sophorolipid dosing
At five weeks of age, equal numbers of wt and Apcmin+/- males and females were placed into
experimental groups. Mice were treated orally (via a sterile p20 pipette tip) every other day
with either vehicle-only or a solution containing 50mg/kg (body weight) of LSL suspended in
0.1% ethanol/ 10% sucrose for 70 days.
Tissue collection and assessment
Mice were euthanized with an overdose of general anesthetic, blood immediately collected by
cardiac puncture into EDTA tubes (Aquilant Scientific, Down, NI) and hematocrit determined
(Cole-parmer, Trickenham,UK). Intestinal tract, colon spleen, heart, liver, kidneys and lungs
were carefully removed, weighed and then fixed in 10% buffered formal saline (pH7.4). The
intestinal tracts were divided into 3 sections according to the description of Casteleyn et al.
(2010) [33]. After identification of the specific intestinal regions, samples were bisected longi-
tudinally and the number of polyps was recorded as well as their diameters measured with cali-
pers. The specimens were then cut into ~2cm strips and placed in cassettes prior to standard
tissue processing and wax embedding. To assess qualitative histopathological changes in
the intestines and spleen, tissues were cut into 5μm sections using a microtome (Shandon;
Cheshire, UK) placed on glass slides, cleared with xylene, dehydrated in descending grades of
ethanol, stained with Mayer’s haematoxylin and eosin stain (Sigma-Aldrich, Dorset, UK) and
examined with a Zeiss light microscope (Axio Scope 1, Zeiss, Germany) at a range of objective
magnifications.
Statistical analysis
Statistical analysis of in vitro data was determined using either one-way ANOVA or student’s
t- test using GraphPad Prism (GraphPad software, San Diego, USA). All comparisons between
in vivo groups were assessed using a students’ t-test. A value of p<0.05 was defined statistically
significant.
Results
Production and purification of LSL
To produce the C18:1 lactonic diacetylated SL used for our in vitro and in vivo studies (Fig 1),
we employed the S. bombicola oe sble strain and a bioreactor experiment similar to one previ-
ously described [30]; however, instead of rapeseed oil, oleic acid was used as the hydrophobic
carbon source. This resulted in a very uniform SL product (Fig 2a) containing 99% SL (97.3%
C18:1 SL [Mw = 688], 1.3% C18:2 SL and 0.4% C18:0 SL).
The purification process was previously described [30] and consists of several washing steps
with demineralized water of the spontaneously precipitated LSL product from the bioreactor.
The washing steps remove hydrophilic impurities such as salts, sugars and proteins from the
water-insoluble LSL. Hydrophobic impurities did not have to be removed, because the feeding
rate of oleic acid was adjusted to its consumption rate, to avoid accumulation and the presence
of an excess of substrate at the end of the fermentation. This is a large advantage, as solvent
extractions to remove oil/fatty acids can be avoided. A final crystallization step of the LSL at
4°C, followed by lyophilisation gave rise to a dry and stable white powder. The final composi-
tion of the sample was analyzed using HPLC-ELSD and determination of possible congeners
Lactonic Sophorolipids Increase Tumor Burden in Apcmin+/- Mice
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(e.g. salts, sugars proteins and oleic acid) was performed. The final purity of the sample was
>99.5% SL and the composition in terms of SL was determined to be 96% diacetylated C18:1
LSL (Mw = 688; Fig 2b), 3.8% diacetylated C18:1 ASL (Mw = 706; Fig 2b) and minor impurities
consisting of 0.04% free fatty acids/oil, 0.001% glucose, 0.004% glycerol and total nitrogen of
0.14%. The ASL was generated by hydrolysis of the LSL in the first step of the purification,
which consisted of heating (65°C) of the culture broth, to melt and subsequently precipitate the
SL product. This process was later optimized in order to avoid this unwanted hydrolysis [30].
LSL have a differential effect on colorectal cell viability
In culture, LSL concentrations above 20μg/ml resulted in reduced viability of both colonic epi-
thelial (CCD-841-CoN) and lung fibroblast (MRC5) cell lines (Fig 3a; p<0.0001), in addition
to Caco2, HCT116 and LS180 colorectal tumor cell lines (Fig 3b; p< 0.05). HT29 cells initially
appear to increase in viability at doses between 20–40μg/ml; however this phenomenon is not
statistically significant from vehicle-only control values (p> 0.05). In both HT29 and HT115
colorectal cancer cell lines a significant decrease in viability was observed at doses exceeding
70μg/ml (p< 0.001; Fig 3b). Microscopic examination of confluent cultures of CCD- 841-CoN
cells revealed a bipolar morphology following exposure to vehicle, whereas at doses of 40
and70 μg/ml there were large areas devoid of cells, with remaining adherent cells displaying a
shrunken and rounded phenotype (Fig 3c: top). In vehicle-treated cultures, HT29 cells display
densely packed, cobblestone-like morphology (Fig 3c: bottom) and there was no obvious
change in phenotype at a dose of 40 μg/ml LSL. In HT29 cells exposed to 70μg/ml LSL, the con-
fluent monolayer was disturbed and there were clear signs of cell rounding and cell-free areas
indicative of detachment (Fig 3c: bottom). Detached cells were isolated from the supernatant of
wells treated with 0, 50 and 100μg/ml LSL to determine if they were alive or dead using propi-
dium iodide and Syto 9 staining. At 50 and 10μg/ml, all cells found in the normal CCD-
841-CoN supernatant were dead (S1A Fig p<0.001). In the cancer cell lines, 4% of cells were
Fig 2. Purification of LSL produced by S. bombicola. HPLC-ELSD and LC-MS analysis of the LSL precipitate from the bioreactor. (a)
The MW 688 g/mol corresponds to diacetyl C18:1 LSL. (b) HPLC-ELSD analysis following purification of the LSL precipitate. The MW 706
g/mol = diacetyl C18:1 ASL, which is the result of minor hydrolysis of the MW 688 compound.
doi:10.1371/journal.pone.0156845.g002
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alive and 96% of detached cells were dead (S1B–S1E Fig p<0.01). At 100μg/ml, all detached
colorectal cancer cells were dead (p<0.001).
LSL induce cell death in vitro
LSL treatment resulted in a higher proportion of cells undergoing necrosis compared to apo-
ptosis in both normal colonic as well as the four colorectal cancer cell lines we examined
Fig 3. LSL administration causes a dose-dependent effect on cell viability andmorphology. (a) Following 24h of treatment with
LSL we observed a significant reduction in O.D.570 values at doses between 20–100μg/ml (p<0.0001) in the control cell lines CCD-
841-CoN and MRC5. (b) There was a significant reduction in O.D.570 values at doses between 30–100μg/ml in HCT116, Caco2 and
LS180 (p < 0.05) and at doses above 60μg/ml inn HT29 and HT115 cells (p < 0.001). Graphs show a representative data set from three
independent experimental replicates. Values indicate mean ± SEM (n = 6). Statistical significance was assessed one-way ANOVA
(*p < 0.05; **p < 0.001; ***p < 0.0001). (c) Light micrographs from CCD-841-CoN colonic epithelial cells (top) treated with vehicle-only
control (left) where cells show a typical bipolar morphology. After treatment with 40μg/ml (central) or 70μg/ml (right) LSL the remaining
adherent cells are rounded and there are large regions devoid of cells. In HT29 cultures treated with vehicle-only (bottom right) the cells
are densely packed with a cobblestone-like morphology. Following treatment with 40μg/ml LSL (middle), there are no discernable
changes in cell morphology, however treatment with 70μg/ml LSL (right) leads to cell rounding and conspicuous cell free areas. Scale
bar = 50μm for all images.
doi:10.1371/journal.pone.0156845.g003
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(Fig 4). In CCD-841-CoN cultures a dose of 20μg/ml LSL resulted in ~70% cell death (Fig 4f),
the majority of which were necrotic (Fig 4p). Both HCT116 (Fig 4i) and Caco2 (Fig 4j) were
susceptible to cell death at a dose of 20μg/ml LSL, while HT29 (Fig 4g) and HT115 (Fig 4h)
were relatively resistant. In CCD-841-CoN cells exposed to 70μg/ml LSL, the few attached cells
Fig 4. LSL induced both necrosis and apoptosis in vitro. Photomicrographs of acridine orange and ethidium bromide stained cultures
following treatments with 0 (a-e), 20 (f-j) or 70μg/ml (k-o) LSL and quantification of live, apoptotic or necrotic cells (p-t). The vast number of
CCD-841-CoN (a) and cancer cells treated with vehicle control are morphologically viable with a small number showing condensed nuclei
(apoptotic). 20μg/ml LSL resulted in necrosis (red/orange clusters) in all cell lines, although CCD-841-CoN (k.p ****p<0.0001) and Caco2
cells (j.o ** p<0.001) were more susceptible. At 70μg/ml, very few adherent CCD-841-CoN cells were observed (k), remaining adhered
cells were either necrotic or apoptotic (p). HT29 (l), HT115 (m), HCT116 (n) and Caco2 (o) cells exposed to 70μg/ml LSL all had 50% of
cells with morphological features of cells death (q-t) and statistically significant increases in either the numbers of necrotic (*** p<0.0001)
or apoptotic cells (**p<0.001) as compared with vehicle only controls.
doi:10.1371/journal.pone.0156845.g004
Lactonic Sophorolipids Increase Tumor Burden in Apcmin+/- Mice
PLOS ONE | DOI:10.1371/journal.pone.0156845 June 6, 2016 8 / 16
available for quantification (Fig 4k) were either necrotic or apoptotic (Fig 4p), whereas in
HT29 (Fig 4l), HT115 (Fig 4m), HCT116 (Fig 4n) and Caco2 (Fig 4o) all showed a significant
increase in both necrotic (p< 0.0001) as well as apoptotic (p< 0.001) cells (Fig 4q–4t) when
compared with vehicle only (Fig 4a–4e).
Oral administration of LSL to Apcmin+/- mice exacerbates tumor
development
Genotyping of mice was undertaken following genomic DNA extraction, PCR and subsequent
restriction enzyme digestion and electrophoresis; this methodology yielded a single 111bp
band for the wt allele or dual 111/123 bp alleles (Fig 5a) that are consistent with a heterozygous
Apcmin+/- mouse. On the basis of genotyping, mice were randomly assigned to either LSL or
vehicle-only dosing groups, irrespective of gender. The weights of both wt and Apcmin+/- mice
fed with either vehicle-only control or LSL solutions were not significantly different (25.2g vs
24.9g NS p< 0.1) and there were no differences in water (98.2ml vs 99ml; NS, p> 0.05) or
food (180.7g vs 178g; NS p> 0.05) consumption over the duration of the experiment. Dosing
of mice for 70 days with LSL also had no effect on the weights of the heart, liver, kidneys or
lungs in wtmice (data not shown). The gross morphological appearance of unfixed flat
mounted ilea from wtmice (Fig 5b top) treated with vehicle-only (left) or 50 mg/kg LSL (right)
was characterized by a flattened, uniformly smooth mucous epithelium. In vehicle-only treated
Apcmin+/- mice (Fig 5b; bottom left), there was clear evidence of occult bleeding throughout the
ileal segment and numerous polyps (modal diameter 2mm; Fig 5d) compared to wtmice. Fol-
lowing treatment with 50mg/kg LSL for 70 days, there is clear evidence of recent bleeding as
well as a greater number (vehicle-only = 55.5 ± 3.3 vs 50mg/kg LSL = 70.5 ± 7.8; Fig 5c;
p< 0.05) of larger diameter (modal size 4mm; Fig 5d; p< 0.001) polyps throughout the ilea
compared to the vehicle only treated Apcmin+/- mice (p< 0.001). Histological features of sec-
tions of wtmouse ilea treated with vehicle or 50mg/kg LSL are characterized by evenly spaced,
narrow villi with mucoid glands at their base (Fig 5e; top). Sections through Apcmin+/- polyps
(Fig 5b; bottom) treated with vehicle- only (left) or 50mg/kg LSL (right) reveals a disturbed vil-
lous architecture lacking epithelial differentiation.
LSL treatment specifically increases splenic weight and red pulp
proportion in the Apcmin+/- mouse
The weights and gross morphological appearances of heart, lungs, kidneys and liver were not
significantly different between either wt and Apcmin+/- mice or between mice fed either vehicle
only or 50mg/kg LSL (NS, p> 0.05; data not shown). Feeding wtmice with either vehicle-only
or 50mg/kg LSL, also did not affect the wet weights of excised spleen (Fig 6a and 6b; NS,
p> 0.05). However, spleens from Apcmin+/- mice were both larger (Fig 6a) and heavier (Fig 6b;
p< 0.0001) than those from wtmice. Administration of 50mg/kg LSL for 70 days to Apcmin+/-
mice also resulted in an increase in splenic size (Fig 6a) and weight (Fig 6b; p< 0.05). Exami-
nation of histological sections from wtmouse spleen (Fig 6c; top) revealed conspicuous
intensely basophilic areas of white pulp, separated by less dense regions of red pulp in the areas
responsible for removal of old or damaged erythrocytes. In Apcmin+/- mice the proportion of
red pulp was increased compared to wt (c.f. Fig 6c top and middle; p< 0.05). Following treat-
ment with 50mg/kg LSL there was a further increase in red pulp size as compared with vehicle-
only controls (c.f. Fig 6c middle and bottom p< 0.05). Hematocrit values were significantly
higher in wt than Apcmin+/- mice (49.5 ± 0.9 vs 38.1± 1.2; p<0.001). Additionally, feeding
Apcmin+/- mice with 50 mg/kg LSL for 70 days caused a significant decrease in hematocrit com-
pared to the vehicle-only control (38.1± 1.2 vs 28.2 ± 1.8; p<0.05).
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Discussion
In order to decrease dependency on petrochemical derived surfactants, biosurfactants are
increasingly finding use in a variety of applications ranging from industrial and household
cleaning reagents through to skin-care products and foodstuffs [8]. The organism with the
highest productivity yield of biosurfactants is the pathogenic species Pseudomonas aeruginosa,
which has made their large scale industrial and health-care use problematic [34]. Modified
Fig 5. LSL treatment increases tumour number and size in Apcmin+/- mice. PCR and restriction enzyme analysis of genomic
DNA from wt or Apcmin+/- littermates (a); wt band: 111bp, heterozygous Apcmin+/- mouse—111 & 123bp. Mice were fed either LSL or
vehicle-only every other day for 70 days. Examination of low power images of intestinal segments from wt mice treated with vehicle
or 50mg/kg LSL revealed no discernible differences in gross morphology (top). However, in Apcmin+/- (bottom), those treated with
vehicle-only (left) showed evidence of occult bleeding (arrow) as well as numerous polyps (c arrow heads) with a modal diameter of
2mm (d). In Apcmin+/- mice treated with LSL, there was evidence of recent hemorrhage (arrows) as well as significant increases in
both polyp number (c;*p <0.01) and size (d;**p < 0.001) compared to vehicle-only controls. Values represent mean ± SEM (n = 10/
group). Statistical significance was determined by one-way ANOVA (c) or a student T-tests (d). (e) Histological sections from wt
(top) or Apcmin+/- (bottom) stained with Haematoxylin and Eosin. Distinct villi in wt treated with vehicle (left) or 50mg/kg LSL are
seen. In Apcmin+/- littermate mice villous structure is grossly perturbed within polyps in both vehicle-treated mice (bottom left) as well
as those treated with 50mg/kg (bottom right).
doi:10.1371/journal.pone.0156845.g005
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strains of the yeast Starmerella bombicola is a potential commercially viable alternative, as it is
non-pathogenic and a high yielding producer of homogenous SL.
In addition to their current commercial uses, SL preparations have previously been
reported to have anti-cancer activity based on their ability to reduce the viability of pancreatic
[19], lung [21], liver [24] and esophageal cancer cells in-vitro. However, these aforementioned
studies are difficult to compare, as inter-study variation is significant and the purity as well as
homogeneity (proportion of sophorolipid species) is often unreported. Since both purity of
SL as well as homogeneity [22] can affect the outcome of biological responses to these mole-
cules, we produced a pure (99% SL) and homogeneous LSL preparation (96% C18:1) for sub-
sequent use in in vitro and in vivo experiments. SL is formed as a complex mixture with
Fig 6. LSL treatment increases spleen size and red pulp area in Apcmin+/- mice. a; Photographs of
dissected spleen from a wt mouse and Apcmin+/- fed with vehicle or LSL. b; Apcmin+/- mice had a significantly
greater spleen weight compared to wt mice (**** p<0.00001). LSL administration resulted in a significant
increase in splenic weights compared to the vehicle control mice (* p<0.01). Splenic histology from wt mice
(6c top), Apcmin+/- mice fed vehicle control only (6c middle) and Apcmin+/- fed LSL (6c bottom). WP =White
pulp, RP = Red pulp, BV = Blood vessel. Apcmin+/- mice demonstrated altered splenic pathology with
increased red pulp regions (hematopoietic rich tissue). LSL fed mice showed a further change in
histopathology (c.f 6c middle vs bottom) with spleens demonstrating a significant increase in red pulp
(* p<0.05). Graphs represented of mean ± SEM. Animals per group n = 10. Statistical significance was
determined by students T-test.
doi:10.1371/journal.pone.0156845.g006
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related species differing by the degree of sophorose acetylation as well as fatty acid length and
saturation. This species diversity, coupled with various congeners found in crude SL prepara-
tions makes separation and purification difficult, demanding and expensive; however it is
vital when considering potential pharma-therapeutic uses. In the past number of years, purifi-
cation of SL has been achieved by the use of thin layer chromatography, HPLC and column
chromatography [35]. The majority of studies investigating the anti-cancer potential of SL
separate and purify samples with the use of HPLC, MS or NMR [19, 21] producing data
showing the exact composition of the SL to be tested, but the information on purity and com-
position is often omitted. One notable study [16] which used pure and well characterized SL
(92% 18:1 LSL) examined their effects on breast carcinoma cells and found a dose-dependent
cytotoxic effect. Here we report on a 96% 18:1 LSL preparation that was used throughout our
in vitro and in vivo experiments. We addressed whether a pure preparation of LSL from Star-
merella bombicola has a differential and/or dose-dependent effect on transformed adherent
cells in comparison to “normal” adherent cells; a highly desirable property for potential can-
cer chemotherapeutics [36]. We assessed five well characterized colorectal cancer cell lines
(HT29, HT115, HCT115, LS180 and CaCo2) in addition to adherent, non-transformed
colonic epithelium (CCD-841-CoN) and lung fibroblasts (MRC5). LSL had the capability to
discriminate in their ability to induce cell death in these cell types; however, they have a more
potent effect against “normal” cells at lower doses (10μg/ml). Only a small number of studies
have been carried out looking at the anti-cancer activities of SL isolated from Starmerella
bombicola, such as the breast cancer line MDA-MB-231 (92% C18:1 LSL). A majority of
studies have been carried out using SL produced byWickerhamiella domercqiae which was
recently identified as C. bombicola after genome sequencing [37]. These cytotoxicity studies
[24], also demonstrate similar potent effect of SL from doses ranging from 40μg/ml– 2mg/ml.
The wide range of dose efficacy may be partially explained by the differences in SL species
and uncharacterized mixtures. The repeatability and high level of consistency in the data
from our in vitro and in vivo studies is consistent with our conclusions on the biological activ-
ity of our LSL sample, although we cannot exclude the possibility that the 3.8% ASL found
within our SL mixture has a co-incident biological activity.
LSL mixtures had no effect on circulating (non-adherent) blood monocytes, although their
comparison with adherent pancreatic tumor cells is spurious. Other non-transformed cell lines
examined in the literature include the uncharacterized, and not readily available HL7702 and
the ‘Chang’ liver cells [24, 25] believed to derived from normal liver, but later found to be HeLa
contaminated [38].
We determined that colorectal cells supplemented with 40–70μg/ml LSL begin to die after
24hr in vitro. The predominant type of cell death observed, following ethidium bromide/acri-
dine orange staining, was necrosis. This occurred at doses of 70μg/ml in the cancer cell lines
and 20μg/ml in the normal cell lines. Necrosis is a type of unregulated programmed cell death
[39], characterized by the disruption of the lipid membrane resulting in the leakage of intracel-
lular proteins, reduction in ATP and cell lysis thus provoking an immune response [40]. SL
induced necrosis has been demonstrated in other cell lines, as quantified by LDH release: such
as HPAC [16] and the HL-60 leukemic cell line [41].
The induction of necrosis in various cell lines (including those described in this study) likely
occurs via the intercalation of biosurfactants into the lipid bilayer as has been previously docu-
mented [42]. Koley et al., 2010 explained that, at a cell-line specific minimal concentration,
surfactants integrate into the cell lipid membrane, resulting in carbon chain structural rear-
rangement. High doses induce tension at the interfacial region of the bilayer, resulting in phos-
pholipid dehydration which affects lipid stability, cellular adhesion and function [43]. This
Lactonic Sophorolipids Increase Tumor Burden in Apcmin+/- Mice
PLOS ONE | DOI:10.1371/journal.pone.0156845 June 6, 2016 12 / 16
ultimately results in cell death [44], which is evident in studies of SL induced membrane dis-
ruption in sperm [18].
Studies investigating the therapeutic potential of SL in vivo are limited with the exception of
sepsis models. SL mixtures reduce mortality in rats with experimentally induced sepsis via
cecum puncture. However in comparison to the natural mixtures—LSL has caused an unex-
pected increase in the mortality rate in the septic rats at the same dose [20].
The Apcmin+/- mouse is a popular animal model to investigate the correlation between
food, genetics and chemotherapeutic in the development of intestinal adenomatous neo-
plasms (polyps). These mice have a life span of <150 days due to secondary consequences of
the disease (extensive bleeding of colonic polyps accompanied by anemia) thus making it an
ideal and quick model to study the effects of compounds [28, 29, 45, 46]. Oral administration
was chosen as the ideal route of administration, in contrast to a traumatic abdominal injury,
as it allows the LSL to have direct access to the gut epithelium and polyps to exert their biolog-
ical effect. Considering the ability of SL mixtures to reduce cancer cell viability, it is surprising
that we could find no reports of the in vivo use of these SL in established pre-clinical models
of cancer development. As our studies indicated an effect of LSL on a range of colorectal
cancer cell lines at dosages that would be tolerated for oral administration, we hypothesized
that long-term administration would slow progression of colorectal tumors in the Apcmin+/-
mouse model.
The results show that orally administered purified LSL did not decrease polyp development,
but instead caused the exacerbated growth of adenomatous polyps in the intestinal pre-cancer-
ous Apcmin+/- mouse model. LSL treatment also increased the size (volume) of the polyps
which is currently used as an indicator of tumor burden [47].
The use of other markers is useful in determining disease progression. Apcmimin+/- naturally
present with an enlarged spleen and reduced hematocrit as a result of colorectal bleeding [45,
46]. Our study showed that LSL administration resulted in a further increase in spleen size and
reduced hematocrit compared to the vehicle control mice. The increase in spleen size may be
due to the role it has in clearing out dead and defective erythrocytes [48]. The effect has been
documented with other drug administration in mice such as benzo(a)pyrene, an immunomod-
ulatory drug [49].
In conclusion, LSL do not discriminate in their ability to induce cell death between trans-
formed and normal cell lines, as well as increasing progression in the pre-clinical Apcmin+/-
mouse model. This study is therefore instructive in urging caution concerning the interpreta-
tion of in vitro studies examining potential anti-tumor effects of purified preparations of LSL
and SL in general.
Supporting Information
S1 Fig. LSL treatment results in the detachment of dead cells. Quantification of live or dead
cells using propidium iodide and Syto 9 staining on cells extracted from the supernatant of cul-
tures treated with 0, 50 or 100μg/ml of LSL. Following treatment with 50μg/ml LSL, CCD-84l
CoN (a), all detached cells in the supernatant were dead ( p<0.001). At the same concentra-
tion, a small number of colorectal cancer cells (b-e) were alive (4%) while the remainder were
dead (96% p< 0.01). In CCD-84l-CoN control cultures and colorectal cancer cells exposed to
100μg/ml LSL, 100% of cells counted in the supernatant were dead ( p<0.0001). Graphs
representative of mean ± SEM. Significance was calculated using a student’s t-test and one-way
ANOVA.
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